About
A spin-out from the University of Oxford, Vivid Dx is a precision diagnostics company transforming pathogen detection and antimicrobial resistance (AMR). The company is developing a next-generation platform to deliver broad pathogen ID in 30 minutes and phenotypic antibiotic susceptibility testing (AST) in 3 hours – directly from blood, with no blood culture required. By combining novel pathogen cell isolation, Raman spectroscopy, a proprietary Raman spectra database, and advanced AI/ML, the platform has the potential to redefine the speed, accuracy, and clinical utility of infectious disease diagnostics. The company is backed by Oxford Science Enterprises and other leading investors.
Technologies
OutlookMicrosoft Office 365Squarespace ECommerceMobile Friendly
Keywords
medical equipment manufacturingsepsis detectionbiotechnologyreal-time pathogen detectiondisruptive healthcare technologyphenotypic astbroad pathogen detectionclinical validationmetabolic activity testingfast pathogen idai-enhanced spectral interpretationspectroscopy-based diagnosticsbiochemical fingerprintdirect-from-blood testinghealthcare equipment & supplies manufacturingai and machine learningmicrofluidic phenotypic testingrapid antimicrobial susceptibilityrapid diagnosticsdisruptive diagnosticsprecision diagnosticsculture-free astai-driven spectral analysisblood pathogen idhealthtechsingle-cell raman fingerprintmetabolic activity raman assayraman spectroscopyspectroscopy for sepsisnext-generation diagnostics
Company Information
- Employees13
- Founded2022
Location
United Kingdom
